XPeng Drops This Tesla Rival Bet Under Pressure
XPeng reported a rare quarterly profit in Q4 2025 but warned of a softer start to 2026, sending shares lower as inves...
What Not To Do When Investing In Cryptocurrency
Investing in cryptocurrency? Discover what not to do to avoid costly mistakes and make informed decisions for a successful investment journey.
26,390 articles
BlinkEx Investment Platform Infrastructure in Early Access
BlinkEx rolls out early-access trading focused on robust infrastructure—fast matching, strong risk controls, and reli...
Clearwater Analytics Stock Lands Big Investment Surge
A major investment move puts Clearwater Analytics stock lands squarely in the spotlight. With 77% ARR growth and chat...
Fed Rate Freeze Tests Gladstone Capital's Recovery
GLAD faces a delicate turning point as the Fed freezes rates, pressuring yields on its floating-rate loans while port...
Kentucky Bill Sparks Backdoor Risk in Crypto Wallets
Kentucky lawmakers are advancing a consumer-protection bill tied to crypto kiosks that could force hardware wallet pr...
Modular Player Scales Urban High-Rise Projects Now
A modular housing developer is pushing into dense city towers, pairing off-site production with new financing models ...
JPMorgan’s Jamie Dimon Says Remote Work Hampers Growth
JPMorgan CEO Jamie Dimon warns that remote work slows learning and career advancement for young bankers, urging more ...
Meta and YouTube Found Liable in Social Media Verdict
A Los Angeles jury finds Meta and YouTube liable on all charges in a landmark social media trial, signaling tighter o...
Vail Resorts Says It’s Time to Rethink the $1,000 Pass
Vail Resorts is signaling a strategic pivot away from the iconic $1,000 Epic Pass as season results lag and weather c...
Analyst Thinks ASML Worth Nearly $2K on EUV Rally Today
A major brokerage lifts its price target for ASML to near $2,000, citing surging EUV demand from DRAM makers and a sw...
Fort Worth Growth Resets the DFW Housing Map in 2026
Fort Worth is reshaping the Dallas-Fort Worth housing map as growth spreads to western suburbs. Analysts say fort wor...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status